32(top 1%)
papers
1.8K(top 1%)
citations
19(top 1%)
h-index
28(top 1%)
g-index
37
all documents
1.9K
doc citations
629
citing journals

Top Articles

#TitleJournalYearCitations
1Safety and Efficacy of Risedronate in Patients With Age-Related Reduced Renal Function as Estimated by the Cockcroft and Gault Method: A Pooled Analysis of Nine Clinical TrialsJournal of Bone and Mineral Research2005272
2Teriparatide in postmenopausal women with osteoporosis and mild or moderate renal impairmentOsteoporosis International2007186
3Efficacy and safety of a once-yearly i.v. Infusion of zoledronic acid 5 mg versus a once-weekly 70-mg oral alendronate in the treatment of male osteoporosis: A randomized, multicenter, double-blind, active-controlled studyJournal of Bone and Mineral Research2010155
4Change in Lumbar Spine BMD and Vertebral Fracture Risk Reduction in Teriparatide-Treated Postmenopausal Women With OsteoporosisJournal of Bone and Mineral Research2006140
5The kidney and bisphosphonatesBone2011131
6Practical Clinical Application of Biochemical Markers of Bone TurnoverJournal of Clinical Densitometry1999127
7Management of severe osteoporosisExpert Opinion on Pharmacotherapy2016107
8Bone Disease in CKD: A Focus on Osteoporosis Diagnosis and ManagementAmerican Journal of Kidney Diseases201497
9Denosumab: Anti-RANKL antibodyCurrent Osteoporosis Reports200996
10Postmenopausal osteoporosis treatment with antiresorptives: Effects of discontinuation or long-term continuation on bone turnover and fracture risk—a perspectiveJournal of Bone and Mineral Research201294
11Increases in BMD Correlate With Improvements in Bone Microarchitecture With Teriparatide Treatment in Postmenopausal Women With OsteoporosisJournal of Bone and Mineral Research200772
12Guidelines for the diagnosis of osteoporosis: T-scores vs fracturesReviews in Endocrine and Metabolic Disorders200769
13Remodeling- and Modeling-Based Bone Formation With Teriparatide Versus Denosumab: A Longitudinal Analysis From Baseline to 3 Months in the AVA StudyJournal of Bone and Mineral Research201863
14Diagnosis and Treatment of Osteoporosis in Chronic Renal DiseaseSeminars in Nephrology200958
15Differential Effects of Teriparatide and Denosumab on Intact PTH and Bone Formation Indices: AVA Osteoporosis StudyJournal of Clinical Endocrinology and Metabolism201652
16Chronic kidney disease and osteoporosis: evaluation and managementBoneKEy Reports201444
17Teriparatide and Bone Turnover and Formation in a Hemodialysis Patient With Low-Turnover Bone Disease: A Case ReportAmerican Journal of Kidney Diseases201533
18Bone and Kidney Disease: Diagnostic and Therapeutic ImplicationsCurrent Rheumatology Reports201232
19Bisphosphonates for the Prevention and Treatment of Corticosteroid-Induced OsteoporosisOsteoporosis International200120
20Rationale, objectives and design of the Direct Analysis of Nonvertebral Fracture in the Community Experience (DANCE) StudyOsteoporosis International200618
21Bone Mass MeasurementsTrends in Endocrinology and Metabolism199711
22Clinical Management of Vertebral Compression FracturesJournal of Clinical Densitometry201611
23Vitamin D, Calcium, and Cardiovascular Mortality: A Perspective from A Plenary Lecture Given at the Annual Meeting of the American Association of Clinical EndocrinologistsEndocrine Practice20118
24The use of risedronate in Paget’s diseaseBone19995
25All Bisphosphonates Are (or May Not Be) the Same: Potential Reasons for Clinical DifferencesJournal of Women's Health20104
26Controversial Issues in Bone DensitometryJournal of Women's Health20023
27New possibilities for diagnosis and treatment of osteoporosisInternational Journal of Fertility and Women's Medicine20013
28The Clinical Application of Gender-Based Databases for the Diagnosis of Osteoporosis and Fracture Risk PredictionInternational Journal of Fertility and Women's Medicine20041
29Monthly ibandronate use is associated with a high percentage of BMD respondersJournal of Clinical Densitometry20070
30Betsy McClung 1942–2015Journal of Bone and Mineral Research20150
31OP0113 Increases in bone mineral density explain the reduction in incidence of nonvertebral fractures seen with antiresorptive therapy in women with postmenopausal osteoporosisJournal of Bone and Mineral Research20010
32Management of Fractures in Men with Impaired Renal FunctionJournal of Bone and Mineral Research20100
33Expanding the List of Etiologic Factors for Osteoporosis in MenEndocrine Practice19970